Western blot analysis of tumor lysates shows that Rac1, Cdc42, or RhoA protein levels were not substantially decreased as a consequence of R-ketorolac treatment in vivo or after 5 days of treatment in cell culture (Additional File 4: Figure S2B, C). The gene discussed is CDC42; the disease is neoplasm.